Important note: Information in this article was accurate in 2003. The state of the art may have changed since the publication date.
Important note: Information in this article was accurate in 2003. The state of the art may have changed since the publication date.
Reuters NewMedia - Thursday October 23, 2003
Bernard Orr
Former President Bill Clinton, whose foundation has been pressing for cheaper treatments, said the more affordable drugs could help millions get a longer lease on life. "There are five to six million people in the developing world with AIDS and in urgent need for the drugs," Clinton told reporters at his Harlem office. "Only 200,000 to 300,000 are receiving treatment. The rest are simply being left to die."
Partnering with three firms in India and South Africa's largest generic drug company, Clinton said antiretroviral drugs will be offered at $140 per person a year, "almost half the current price of inexpensive commonly used drugs."
Human right groups lauded the move.
"For AIDS treatment rates in poor countries to go up, prices have to come down. Today's announcement marks a crucial breakthrough in the AIDS emergency," said Bono, human rights activist and lead singer of rock band U2.
The William J. Clinton Presidential Foundation HIV/AIDS Initiative said the plan would get the cheaper drugs to about two million people by 2008.
Worldwide, an estimated 42 million people suffer from HIV and AIDS.
Chopping the price of drugs in half is a huge issue for poor African countries, where many people survive on as little as $300 a year.
Ranbaxy Laboratories Ltd., Cipla Ltd. and Matrix Laboratories Ltd., all of India, and South Africa's Aspen Pharmacare Holdings, will manufacture and distribute two of the most commonly used combination drug-therapy cocktails.
Clinton said the foundation sent teams of health and business professionals to work with the companies to identify ways to slash costs and trim profits to a bare minimum.
So far, patients in the Dominican Republic and the Bahamas have received the drugs on a limited basis.
Clinton said Mozambique, Rwanda and Tanzania and South Africa will start receiving the drugs soon.
031023
RE031026
Copyright © 2003 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .